NanoString Technologies Inc. (NSTG) CFO James A. Johnson Sells 10,000 Shares
NanoString Technologies Inc. (NASDAQ:NSTG) CFO James A. Johnson sold 10,000 shares of the stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $22.57, for a total transaction of $225,700.00. Following the transaction, the chief financial officer now owns 10,698 shares in the company, valued at approximately $241,453.86. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of NanoString Technologies Inc. (NASDAQ:NSTG) opened at 22.87 on Tuesday. The stock’s 50 day moving average is $20.43 and its 200-day moving average is $16.30. NanoString Technologies Inc. has a one year low of $11.30 and a one year high of $23.45. The company’s market cap is $480.36 million.
NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.51) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.52) by $0.01. NanoString Technologies had a negative net margin of 53.02% and a negative return on equity of 784.63%. The company had revenue of $23.90 million for the quarter, compared to analyst estimates of $23.46 million. During the same period last year, the firm earned ($0.49) earnings per share. The firm’s revenue was up 52.2% on a year-over-year basis. Equities research analysts forecast that NanoString Technologies Inc. will post ($2.21) earnings per share for the current year.
A number of research analysts have issued reports on NSTG shares. BTIG Research restated a “buy” rating and set a $20.00 target price on shares of NanoString Technologies in a research report on Friday, August 5th. Zacks Investment Research upgraded shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $15.00 target price on the stock in a research report on Friday, July 29th. One analyst has rated the stock with a sell rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $18.50.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC purchased a new position in NanoString Technologies during the second quarter worth $532,000. Strs Ohio raised its stake in shares of NanoString Technologies by 8.5% in the second quarter. Strs Ohio now owns 31,900 shares of the company’s stock valued at $401,000 after buying an additional 2,500 shares in the last quarter. Quantitative Systematic Strategies LLC bought a new stake in shares of NanoString Technologies during the second quarter valued at approximately $211,000. Bank of New York Mellon Corp raised its stake in shares of NanoString Technologies by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 97,569 shares of the company’s stock valued at $1,229,000 after buying an additional 7,272 shares in the last quarter. Finally, California State Teachers Retirement System raised its stake in shares of NanoString Technologies by 9.4% in the second quarter. California State Teachers Retirement System now owns 31,067 shares of the company’s stock valued at $391,000 after buying an additional 2,658 shares in the last quarter. 87.09% of the stock is currently owned by institutional investors.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops and manufactures intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company operates in the segment of development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Stock Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related stocks with our FREE daily email newsletter.